The two pathways do not simply add together
However, so far across studies with GLP1R agonists , cardiovascular measurements such as blood pressure have seen improvements in general, with no significant increases in adverse cardiovascular effects seen in patients even after 2 years (In fact, decreases were seen), suggesting that the cardiovascular benefits of decreased body weight may overcome any potential harm that increases in heart rate by GLP1R agonists may cause
6 Nervous system Insulin resistance is a common feature in neurodegenerative disease, and research shows that T2D is a risk factor for Alzheimers disease (AD) and Parkinsons disease (PD)
Easy Rule of Thumb If there is ANY sudden change in consciousness, breathing, heart function, or behavior: CALL 911 and GO to the ER
Tablet & Injection Options : Whether you prefer oral convenience or injectable consistency, MEDVi provides both , with clear instruction and support
In February 2025, the FDA announced that the shortage of semaglutide injectable products (Ozempic, Wegovy) has been resolved, Dulaglutide (Trulicity) shortage resolved in June 2025